Inserra, C., Zovi, A., Scalzi, V., Zampogna, L., Vimercati, S., Piacenza, M., & Zerega, G. (2018). 6ER-010 Focus on hcv treatment based on second-generation direct-acting antiviral agents (daas-2): Comparing national and local prescribing trends. Eur J Hosp Pharm.
Style de citation ChicagoInserra, C., A. Zovi, V. Scalzi, L. Zampogna, S. Vimercati, M. Piacenza, et G. Zerega. "6ER-010 Focus On Hcv Treatment Based On Second-generation Direct-acting Antiviral Agents (daas-2): Comparing National and Local Prescribing Trends." Eur J Hosp Pharm 2018.
Style de citation MLAInserra, C., et al. "6ER-010 Focus On Hcv Treatment Based On Second-generation Direct-acting Antiviral Agents (daas-2): Comparing National and Local Prescribing Trends." Eur J Hosp Pharm 2018.